Stefan Grimm

Max Planck Society, Imperial College London, Max Planck Institute of Biochemistry, Hammersmith Hospital

Papers

Total Citations

182

H-Index

About

Stefan Grimm is a molecular biologist whose research has made significant contributions to our understanding of apoptosis, high-throughput genetic screening, and functional genomics in mammalian systems. His most influential work, "The art and design of genetic screens: mammalian culture cells" (2004, 124 citations), established foundational principles for conducting systematic genetic screens in mammalian cell culture — a methodological advance that has guided countless downstream studies in cell biology and cancer research. Grimm has been a pioneer in developing robotic and high-throughput platforms to accelerate functional genomics. His 2002 study introduced an automated screen capable of identifying apoptosis-inducing genes through transient transfection, directly addressing the challenge of assigning biological function to the flood of sequence data emerging from genome projects. Complementing this, his 2006 work on robotic plasmid DNA isolation provided the scalable infrastructure necessary for such large-scale investigations. A central theme throughout his career is mitochondrial apoptosis control, explored through innovative cell culture screening approaches. By systematically interrogating gene function at scale, Grimm has helped bridge the gap between genomic sequence data and cellular mechanism — offering tools and insights that remain valuable to researchers working at the intersection of genetics, cell death, and disease.